Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | 2C5H6NO3.Mg |
| Molecular Weight | 280.5171 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Mg++].[O-]C(=O)[C@@H]1CCC(=O)N1.[O-]C(=O)[C@@H]2CCC(=O)N2
InChI
InChIKey=JQAACYUZYRBHGG-QHTZZOMLSA-L
InChI=1S/2C5H7NO3.Mg/c2*7-4-2-1-3(6-4)5(8)9;/h2*3H,1-2H2,(H,6,7)(H,8,9);/q;;+2/p-2/t2*3-;/m00./s1
| Molecular Formula | Mg |
| Molecular Weight | 24.305 |
| Charge | 2 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C5H6NO3 |
| Molecular Weight | 128.106 |
| Charge | -1 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DescriptionSources: http://www.currentscience.ac.in/Volumes/102/02/0288.pdfhttps://www.drugs.com/otc/121041/cleansing-foaming-gel-acne-pro-skin.html | https://www.ncbi.nlm.nih.gov/pubmed/25727335 | https://www.ncbi.nlm.nih.gov/pubmed/21834944 | https://www.ulprospector.com/en/na/PersonalCare/Detail/6637/223524/EcoCare-Zinclean | http://www.scalp-health.com/zinc-pca.htmCurator's Comment: description was created based on several sources, including
http://www.cir-safety.org/sites/default/files/pca.pdf
Sources: http://www.currentscience.ac.in/Volumes/102/02/0288.pdfhttps://www.drugs.com/otc/121041/cleansing-foaming-gel-acne-pro-skin.html | https://www.ncbi.nlm.nih.gov/pubmed/25727335 | https://www.ncbi.nlm.nih.gov/pubmed/21834944 | https://www.ulprospector.com/en/na/PersonalCare/Detail/6637/223524/EcoCare-Zinclean | http://www.scalp-health.com/zinc-pca.htm
Curator's Comment: description was created based on several sources, including
http://www.cir-safety.org/sites/default/files/pca.pdf
Zinc Pidolate (Zinc PCA) is a topical skin product with purifying, astingent, anti-inflammatory, antiseptic activity. It has long been used as a cosmetic ingredient, because of its astringent and anti-microbial properties. Zinc Pidolate has also being shown to be effective against halitosis. Zinc PCA prevents the UV-induced MMP-1 production in vitro by suppressing the activation of AP-1. Zinc PCA was also able to enhance type I collagen synthesis in NHDFs, by increasing the expression of the mRNA encoding the ascorbic acid transporter SVCT2 in non-UV irradiated
NHDFs, which suggests its promising effect against not only photoaged skin but also for the simple atrophic change of intrinsic skin ageing. Zinc PCA is able to suppress sebum secretion by inhibiting 5-α reductase in hyperseborrhea, to suppress body odor by forming zinc salts with short-chain fatty acids, to suppress wrinkles by inhibiting AP-1 to and inhibit bacterial growth including acne related Propionibacterium acnes.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL3271 |
|||
Target ID: P02452|||Q15176|||Q9UML6 Gene ID: 1277.0 Gene Symbol: COL1A1 Target Organism: Homo sapiens (Human) |
|||
Target ID: CHEMBL2111421 |
|||
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Preventing | CLEANSING FOAMING GEL ACNE PRO SKIN- zinc pidolate gel Approved UseLange Gel will turn into foam, during application. It will cleanse skin thoroughly without any dryness effect, in order to avoid hyperseboohea phenomenon, a main cause of acne. Launch Date2012 |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | EcoCare™ Zinclean Approved UseUse in anti-dandruff shampoos |
|||
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| CFSUM1 and CFSUM2 in urine from patients with chronic fatigue syndrome are methodological artefacts. | 2006-02 |
|
| Familial Danish dementia: co-existence of Danish and Alzheimer amyloid subunits (ADan AND A{beta}) in the absence of compact plaques. | 2005-11-04 |
|
| Thermostability and in vitro digestibility of a purified major allergen 2S albumin (Ses i 1) from white sesame seeds (Sesamum indicum L.). | 2005-09-25 |
|
| Synthesis of 1,3-dioxo-hexahydropyrido[1,2-c][1,3]diazepine carboxylates, a new bicyclic skeleton formed by ring expansion-RCM methodology. | 2005-09-21 |
|
| Cloning, expression, characterization, and crystallization of a glutaminyl cyclase from human bone marrow: a single zinc metalloenzyme. | 2005-09 |
|
| Stereoselective synthesis of conformationally constrained omega-amino acid analogues from pyroglutamic acid. | 2005-08-07 |
|
| Nanoparticles on the basis of highly functionalized dextrans. | 2005-08-03 |
|
| Formation of extracellular glutamate from glutamine: exclusion of pyroglutamate as an intermediate. | 2005-08-02 |
|
| Emerging roles of apelin in biology and medicine. | 2005-08 |
|
| CLPM: a cross-linked peptide mapping algorithm for mass spectrometric analysis. | 2005-07-15 |
|
| Total synthesis of pinnamine and anatoxin-a via a common intermediate. A caveat on the anatoxin-a endgame. | 2005-07-08 |
|
| The removal of pyroglutamic acid from monoclonal antibodies without denaturation of the protein chains. | 2005-07-01 |
|
| Acetaminophen-induced anion gap metabolic acidosis and 5-oxoprolinuria (pyroglutamic aciduria) acquired in hospital. | 2005-07 |
|
| Recurrent high anion gap metabolic acidosis secondary to 5-oxoproline (pyroglutamic acid). | 2005-07 |
|
| Identification of novel bradykinin-potentiating peptides and C-type natriuretic peptide from Lachesis muta venom. | 2005-07 |
|
| Biomarker metabolites capturing the metabolite variance present in a rice plant developmental period. | 2005-05-31 |
|
| Bromophenols coupled with derivatives of amino acids and nucleosides from the red alga Rhodomela confervoides. | 2005-05 |
|
| Anuroctoxin, a new scorpion toxin of the alpha-KTx 6 subfamily, is highly selective for Kv1.3 over IKCa1 ion channels of human T lymphocytes. | 2005-04 |
|
| Preparation and reactivity of aminoacyl pyroglutamates. Facile synthesis of 10-membered-ring cyclic dipeptides derived from 1,4-diaminobutyric and glutamic acids. | 2005-03 |
|
| Physiological and pathological aspects of GSH metabolism. | 2005-02 |
|
| A high-throughput liquid chromatography/tandem mass spectrometry method for screening glutathione conjugates using exact mass neutral loss acquisition. | 2005 |
|
| The computer modelling of human TRH receptor, TRH and TRH-like peptides. | 2005 |
|
| Alpha-tocopherol pro-vitamins: synthesis, hydrolysis and accumulation in rabbit ear skin. | 2004-10-19 |
|
| Discrepin, a new peptide of the sub-family alpha-ktx15, isolated from the scorpion Tityus discrepans irreversibly blocks K+ -channels (IA currents) of cerebellum granular cells. | 2004-10-15 |
|
| Mass spectrometry analysis of recombinant human ZP3 expressed in glycosylation-deficient CHO cells. | 2004-09-28 |
|
| The development of a higher throughput reactive intermediate screening assay incorporating micro-bore liquid chromatography-micro-electrospray ionization-tandem mass spectrometry and glutathione ethyl ester as an in vitro conjugating agent. | 2004-09-21 |
|
| Isolation of an anti-angiogenic substance from Agaricus blazei Murill: its antitumor and antimetastatic actions. | 2004-09 |
|
| Obligatory involvement of CD26/dipeptidyl peptidase IV in the activation of the antiretroviral tripeptide glycylprolylglycinamide (GPG-NH(2)). | 2004-09 |
|
| Glutamine in commercial liquid nutritional products. | 2004-08-11 |
|
| Integrative annotation of 21,037 human genes validated by full-length cDNA clones. | 2004-06 |
|
| Mass spectrometric analysis of posttranslational modifications of a carrot extracellular glycoprotein. | 2004-05-25 |
|
| Skin secretion of the toad Bombina variegata contains multiple insulin-releasing peptides including bombesin and entirely novel insulinotropic structures. | 2004-05-12 |
|
| Synthesis of (2S,3R)-[3',3',3'-2H3]-valine and (2S,3S)-4-fluorovaline. | 2004-05-07 |
|
| Origin of diastereoselection in the hydrosilylation of chiral N-acyliminium intermediates derived from pyroglutamic acid. | 2004-04-26 |
|
| Preventing the spontaneous modification of an HLA-A2-restricted peptide at an N-terminal glutamine or an internal cysteine residue enhances peptide antigenicity. | 2004-04-13 |
|
| Glutaminyl cyclases unfold glutamyl cyclase activity under mild acid conditions. | 2004-04-09 |
|
| Synthesis of (2S,3S)-3'-fluoroisoleucine. | 2004-03-07 |
|
| Chemical characterization of a lambda I amyloid protein isolated from formalin-fixed and paraffin-embedded tissue sections. | 2004-03 |
|
| Unexplained metabolic acidosis in critically ill patients: the role of pyroglutamic acid. | 2004-03 |
|
| Identification of endogenous phosphorylation sites of bovine medium and low molecular weight neurofilament proteins by tandem mass spectrometry. | 2004-02-24 |
|
| Human glutaminyl cyclase and bacterial zinc aminopeptidase share a common fold and active site. | 2004-02-10 |
|
| Toward the synthesis of pyroglutamate lauroyl ester: biocatalysis versus chemical catalysis. | 2004-02 |
|
| Stabilization of peptide guinea pig myelin basic protein 72-85 by N-terminal acetylation-implications for immunological studies. | 2004-02 |
|
| Expression, purification, and characterization of avian Thy-1 from Lec1 mammalian and Tn5 insect cells. | 2004-02 |
|
| [Characteristics of pyrrolidone pharmacokinetics in rats]. | 2004-01-28 |
|
| N-acetylation of the glutamate residue of intact glutathione conjugates in rats: a novel pathway for the metabolic processing of thiol adducts of xenobiotics. | 2004-01 |
|
| Pressure/temperature combined treatments of precursors yield hormone-like peptides with pyroglutamate at the N terminus. | 2003-12-31 |
|
| Determination of the post-translational modifications of salivary acidic proline-rich proteins. | 2003-04 |
|
| Characterizing degradation products of peptides containing N-terminal Cys residues by (off-line high-performance liquid chromatography)/matrix-assisted laser desorption/ionization quadrupole time-of-flight measurements. | 2003 |
|
| Human seminal relaxin is a product of the same gene as human luteal relaxin. | 1992-05 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:32:22 GMT 2025
by
admin
on
Mon Mar 31 18:32:22 GMT 2025
|
| Record UNII |
V5PC588N7G
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-VATC |
QA12CC08
Created by
admin on Mon Mar 31 18:32:22 GMT 2025 , Edited by admin on Mon Mar 31 18:32:22 GMT 2025
|
||
|
WHO-ATC |
A12CC08
Created by
admin on Mon Mar 31 18:32:22 GMT 2025 , Edited by admin on Mon Mar 31 18:32:22 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
MAGNESIUM PIDOLATE
Created by
admin on Mon Mar 31 18:32:22 GMT 2025 , Edited by admin on Mon Mar 31 18:32:22 GMT 2025
|
PRIMARY | |||
|
DBSALT002689
Created by
admin on Mon Mar 31 18:32:22 GMT 2025 , Edited by admin on Mon Mar 31 18:32:22 GMT 2025
|
PRIMARY | |||
|
CHEMBL397976
Created by
admin on Mon Mar 31 18:32:22 GMT 2025 , Edited by admin on Mon Mar 31 18:32:22 GMT 2025
|
PRIMARY | |||
|
V5PC588N7G
Created by
admin on Mon Mar 31 18:32:22 GMT 2025 , Edited by admin on Mon Mar 31 18:32:22 GMT 2025
|
PRIMARY | |||
|
V5PC588N7G
Created by
admin on Mon Mar 31 18:32:22 GMT 2025 , Edited by admin on Mon Mar 31 18:32:22 GMT 2025
|
PRIMARY | |||
|
14559042
Created by
admin on Mon Mar 31 18:32:22 GMT 2025 , Edited by admin on Mon Mar 31 18:32:22 GMT 2025
|
PRIMARY | |||
|
100000089075
Created by
admin on Mon Mar 31 18:32:22 GMT 2025 , Edited by admin on Mon Mar 31 18:32:22 GMT 2025
|
PRIMARY | |||
|
116240
Created by
admin on Mon Mar 31 18:32:22 GMT 2025 , Edited by admin on Mon Mar 31 18:32:22 GMT 2025
|
PRIMARY | RxNorm | ||
|
4597
Created by
admin on Mon Mar 31 18:32:22 GMT 2025 , Edited by admin on Mon Mar 31 18:32:22 GMT 2025
|
PRIMARY | |||
|
263-365-7
Created by
admin on Mon Mar 31 18:32:22 GMT 2025 , Edited by admin on Mon Mar 31 18:32:22 GMT 2025
|
PRIMARY | |||
|
SUB03045MIG
Created by
admin on Mon Mar 31 18:32:22 GMT 2025 , Edited by admin on Mon Mar 31 18:32:22 GMT 2025
|
PRIMARY | |||
|
62003-27-4
Created by
admin on Mon Mar 31 18:32:22 GMT 2025 , Edited by admin on Mon Mar 31 18:32:22 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |